Invention Grant
- Patent Title: Substituted imidazole compounds as KSP inhibitors
- Patent Title (中): 取代的咪唑化合物作为KSP抑制剂
-
Application No.: US11502303Application Date: 2006-08-09
-
Publication No.: US07626040B2Publication Date: 2009-12-01
- Inventor: Paul A. Barsanti , Yi Xia , Weibo Wang , Kris G. Mendenhall , Liana M. Lagniton , Savithri Ramurthy , Megan C. Phillips , Sharadha Subramanian , Rustum Boyce , Nathan M. Brammeier , Ryan Constantine , David Duhl , Annette O. Walter , Tinya J. Abrams , Paul A. Renhowe
- Applicant: Paul A. Barsanti , Yi Xia , Weibo Wang , Kris G. Mendenhall , Liana M. Lagniton , Savithri Ramurthy , Megan C. Phillips , Sharadha Subramanian , Rustum Boyce , Nathan M. Brammeier , Ryan Constantine , David Duhl , Annette O. Walter , Tinya J. Abrams , Paul A. Renhowe
- Applicant Address: US CA Emeryville
- Assignee: Novartis Vaccines and Diagnostics, Inc.
- Current Assignee: Novartis Vaccines and Diagnostics, Inc.
- Current Assignee Address: US CA Emeryville
- Agent Vinit Kathardekar; Lorna Tanner
- Main IPC: C07D233/64
- IPC: C07D233/64 ; C07D401/12 ; C07D279/12 ; C07D413/12 ; C07D403/12
Abstract:
The present invention relates to new substituted imidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the derivatives together with pharmaceutically acceptable carriers, and uses of the compounds. The compounds of the invention have the following general formula:
Public/Granted literature
- US20070037853A1 Substituted imidazole compounds as KSP inhibitors Public/Granted day:2007-02-15
Information query
